1.0
Jun 27, 2018
Current employee, more than 3 years
New York, NY
Recommend
CEO approval
Business Outlook
Pros
Money is good with OT and Bonus
Cons
The Histology/Pathology part of the company (formally Dako) has not made money in 3 years, the joke among the executives is when will the Diagnostic group pull their weight and start making money, they took on Quest Labs and over promised and now they are struggling due to issues with reliability on the Omnis platform more and more the engineers are putting band aids trying to keep the jugular vein from bleeding out. Poor working conditions and has turned into finger pointing rather than to find solutions.